(Bloomberg) -- Contemporary Amperex Technology Co. Ltd. has started taking investor orders for a Hong Kong stock offering that is likely to be the world’s biggest listing this year. Most Read from Bloomberg A New Central Park Amenity, Tailored to Its East Harlem Neighbors As Trump Reshapes Housing Policy, Renters Face Rollback of Rights Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic? What’s Behind the Rise in Serious Injuries on New York City’s Streets? NYC Warns of 17% Drop in Foreign Tourists Due to Trump Policies CATL, as the Chinese electric-vehicle battery giant is known, is seeking to raise as much as HK$41 billion ($5.3 billion), according to its listing document on Monday. That’s if the deal is upsized and the greenshoe exercised on top of the base offering of up to HK$31 billion. The Fujian-based company is marketing shares at a maximum price of HK$263 each, or 1.4% lower than Friday’s close in Shenzhen but roughly equivalent to Thursday’s. Pricing could be decided as soon as Tuesday and the stock is expected to begin trading May 20. The share offering would more than double proceeds in Hong Kong’s market for listings this year, which Bloomberg Intelligence predicts will surge to more than $22 billion. The bonanza’s been driven by Chinese companies going ahead with their listing plans in the Asian financial hub despite the turmoil brought on by US President Donald Trump’s tariffs, which have caused many deals to be postponed in America and Europe. CATL shares rose as much as 3.4% in Shenzhen trading, outperforming the benchmark index. CATL is offering about 118 million shares in the base offering, which could increase to around 136 million if the company upsizes the deal by 15%. With the greenshoe option, the company would be selling nearly 156 million shares. Cornerstone investors, which agree to hold shares from the deal for at least six months, have committed to buy about $2.6 billion worth of stock, according to the prospectus. They include Chinese state-owned oil company Sinopec, the Kuwait Investment Authority and alternative-asset manager Hillhouse Investment. CATL said it was doing the deal in the form of a so-called Regulation S offering, which doesn’t allow sales to US onshore investors and exempts the issuer from certain US regulatory filing obligations, confirming an earlier Bloomberg News report. The limitations on certain types of US investors indicates that US-China tensions may be spilling into the new-listings landscape. The company also received a waiver from the Hong Kong exchange on the need to carry out a clawback mechanism, which would have required it to allocate more shares to retail investors if demand were high enough, according to the prospectus. The waiver allows for institutional investors to maintain a larger proportion of shares allocated for the Hong Kong listing. Story Continues The share offering would more than double proceeds in Hong Kong’s market for listings this year, which Bloomberg Intelligence predicts will surge to more than $22 billion. The bonanza’s been driven by Chinese companies going ahead with their listing plans in the Asian financial hub despite the turmoil brought on by US President Donald Trump’s tariffs, which have caused many deals to be postponed in America and Europe. The deal hasn’t come without hurdles. The company was put on a Pentagon blacklist in January based on allegations of CATL’s links to the Chinese military — something the company has denied repeatedly. The heat has spread to even some of the banks arranging the deal. In April, a US congressional committee publicly called on JPMorgan Chase & Co. and Bank of America Corp. to stop working on the listing because of CATL’s alleged military links — again, denied by the company. But both American banks stuck with the deal. After the sale, CATL plans to use much of the proceeds for its ongoing international expansion in Europe, especially for a big factory in Hungary to supply top clients like Mercedes-Benz. That may help the company widen its lead in the industry, where it has a a market share of roughly 38%, comfortably ahead of its closest challenger, top EV maker BYD Co.’s 17%, according to SNE Research. As for Hong Kong, the deals keep on rolling. Chinese cancer drugmaker Jiangsu Hengrui Pharmaceuticals Co. is also gearing up for a big listing this month, people familiar with the matter have said. Besides JPMorgan and Bank of America, joint sponsors of CATL’s offering include China International Capital Corp. and China Securities International. Goldman Sachs Group Inc., Morgan Stanley and UBS Group AG are also arranging the deal. CATL said it would pay the underwriters a fixed fee of 0.2% of the deal, including shares to be issued if the offering gets upsized and the greenshoe option is exercised. The banks may also receive a 0.6% incentive fee. (Updates with details about the breakdown of offered shares in the fourth paragraph, shares on in fifth, waiver on clawback in seventh and bank fees in the penultimate paragraph.) Most Read from Bloomberg Businessweek US Border Towns Are Being Ravaged by Canada’s Furious Boycott How the Lizard King Built a Reptile Empire Selling $50,000 Geckos Maybe AI Slop Is Killing the Internet, After All With the New York Liberty, Clara Wu Tsai Aims for the First $1 Billion Women’s Sports Franchise Pre-Tariff Car Buying Frenzy Leaves Americans With a Big Debt Problem ©2025 Bloomberg L.P. View Comments
CATL Starts Taking Investor Orders for World’s Biggest Listing This Year
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...